Jai Sidpra,Sniya Sudhakar,Asthik Biswas,Flavia Massey,Valentina Turchetti,Tracy Lau,Edward Cook,Javeria Raza Alvi,Hasnaa M Elbendary,Jerry L Jewell,Antonella Riva,Alessandro Orsini,Aglaia Vignoli,Zara Federico,Jessica Rosenblum,An-Sofie Schoonjans,Matthias de Wachter,Ignacio Delgado Alvarez,Ana Felipe-Rucián,Nourelhoda A Haridy,Shahzad Haider,Mashaya Zaman,Selina Banu,Najwa Anwaar,Fatima Rahman,Shazia Maqbool,Rashmi Yadav,Vincenzo Salpietro,Reza Maroofian,Rajan Patel,Rupa Radhakrishnan,Sanjay P Prabhu,Klaske Lichtenbelt,Helen Stewart,Yoshiko Murakami,Ulrike Löbel,Felice D'Arco,Emma Wakeling,Wendy Jones,Eleanor Hay,Sanjay Bhate,Thomas S Jacques,David M Mirsky,Matthew T Whitehead,Maha S Zaki,Tipu Sultan,Pasquale Striano,Anna C Jansen,Maarten Lequin,Linda S de Vries,Mariasavina Severino,Andrew C Edmondson,Lara Menzies,Philippe M Campeau,Henry Houlden,Amy McTague,Stephanie Efthymiou,Kshitij Mankad

Abstract:Inherited glycosylphosphatidylinositol deficiency disorders (IGDs) are a group of rare multisystem disorders arising from pathogenic variants in glycosylphosphatidylinositol anchor pathway (GPI-AP) genes. Despite associating 24 of at least 31 GPI-AP genes with human neurogenetic disease, prior reports are limited to single genes without consideration of the GPI-AP as a whole and with limited natural history data. In this multinational retrospective observational study, we systematically analyse the molecular spectrum, phenotypic characteristics, and natural history of 83 individuals from 75 unique families with IGDs, including 70 newly reported individuals: the largest single cohort to date. Core clinical features were developmental delay or intellectual disability (DD/ID, 90%), seizures (83%), hypotonia (72%), and motor symptoms (64%). Prognostic and biologically significant neuroimaging features included cerebral atrophy (75%), cerebellar atrophy (60%), callosal anomalies (57%), and symmetric restricted diffusion of the central tegmental tracts (60%). Sixty-one individuals had multisystem involvement including gastrointestinal (66%), cardiac (19%), and renal (14%) anomalies. Though dysmorphic features were appreciated in 82%, no single dysmorphic feature had a prevalence >30%, indicating substantial phenotypic heterogeneity. Follow-up data were available for all individuals, 15 of whom were deceased at the time of writing. Median age at seizure onset was 6 months. Individuals with variants in synthesis stage genes of the GPI-AP exhibited a significantly shorter time to seizure onset than individuals with variants in transamidase and remodelling stage genes of the GPI-AP (P=0.046). Forty individuals had intractable epilepsy. The majority of individuals experienced delayed or absent speech (95%); motor delay with non-ambulance (64%); and severe-to-profound DD/ID (59%). Individuals with a developmental epileptic encephalopathy (51%) were at greater risk of intractable epilepsy (P=0.003), non-ambulance (P=0.035), ongoing enteral feeds (P<0.001), and cortical visual impairment (P=0.007). Serial neuroimaging showed progressive cerebral volume loss in 87.5% and progressive cerebellar atrophy in 70.8%, indicating a neurodegenerative process. Genetic analyses identified 93 unique variants (106 total), including 22 novel variants. Exploratory analyses of genotype-phenotype correlations using unsupervised hierarchical clustering identified novel genotypic predictors of clinical phenotype and long-term outcome with meaningful implications for management. In summary, we expand both the mild and severe phenotypic extremities of the IGDs; provide insights into their neurological basis; and, vitally, enable meaningful genetic counselling for affected individuals and their families.

Phenotype-genotype correlations of PIGO deficiency with variable phenotypes from infantile lethality to mild learning difficulties

PIGO-CDG: A case study with a new genotype, expansion of the phenotype, literature review, and nosological considerations

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes

The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders

Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis

Two Different Brain Injury Patterns Associated with Compound Heterozygosis of the PIGO Gene in a Term Newborn: A Case Report

Missense variant in PIGM associated with severe cystic encephalomalacia and portal vein thrombosis: Phenotypic and genotypic expansion of the glycosylphosphatidylinositol biosynthesis defect-1 (GPIBD1)

PIGA mutations cause early-onset epileptic encephalopathies and distinctive features

A novel homozygous variant of the PIGK gene caused by paternal disomy in a patient with neurodevelopmental disorder, cerebellar atrophy, and seizures

GPIアンカーとその欠損症

Recessive Variants in PIGG Cause a Motor Neuropathy with Variable Conduction Block, Childhood Tremor, and Febrile Seizures: Expanding the Phenotype

PIGW-related glycosylphosphatidylinositol deficiency: A case report and literature review

Case Report: Compound Heterozygous Phosphatidylinositol-Glycan Biosynthesis Class N (PIGN) Mutations in a Chinese Fetus With Hypotonia-Seizures Syndrome 1

Congenital diaphragmatic hernia and early lethality in PIGL-related disorder

Inherited glycosylphosphatidylinositol deficiency: a review from molecular and clinical perspectives

Loss of PIGK Function Causes Severe Infantile Encephalopathy and Extensive Neuronal Apoptosis.

Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders

Clinical phenotype and mutation characteristics of germline PIGA gene mutations

Cerebral visual impairment and intellectual disability caused by PGAP1 variants

INPP4A-related genetic and phenotypic spectrum and functional relevance of subcellular targeting of INPP4A isoforms